Lymphatics

  • 3E0W Lymphatics
    • 3E0W3 Percutaneous
      • 3E0W30 Antineoplastic
        • 3E0W305 Introduction of Other Antineoplastic into Lymphatics, Percutaneous Approach
        • 3E0W30M Introduction of Antineoplastic, Monoclonal Antibody, into Lymphatics, Percutaneous Approach
      • 3E0W32 Anti-infective
        • 3E0W328 Introduction of Oxazolidinones into Lymphatics, Percutaneous Approach
        • 3E0W329 Introduction of Other Anti-infective into Lymphatics, Percutaneous Approach
      • 3E0W33 Anti-inflammatory
        • 3E0W33Z Introduction of Anti-inflammatory into Lymphatics, Percutaneous Approach
      • 3E0W36 Nutritional Substance
        • 3E0W36Z Introduction of Nutritional Substance into Lymphatics, Percutaneous Approach
      • 3E0W37 Electrolytic and Water Balance Substance
        • 3E0W37Z Introduction of Electrolytic and Water Balance Substance into Lymphatics, Percutaneous Approach
      • 3E0W3B Anesthetic Agent
        • 3E0W3BZ Introduction of Anesthetic Agent into Lymphatics, Percutaneous Approach
      • 3E0W3G Other Therapeutic Substance
        • 3E0W3GC Introduction of Other Therapeutic Substance into Lymphatics, Percutaneous Approach
      • 3E0W3H Radioactive Substance
        • 3E0W3HZ Introduction of Radioactive Substance into Lymphatics, Percutaneous Approach
      • 3E0W3K Other Diagnostic Substance
        • 3E0W3KZ Introduction of Other Diagnostic Substance into Lymphatics, Percutaneous Approach
      • 3E0W3N Analgesics, Hypnotics, Sedatives
        • 3E0W3NZ Introduction of Analgesics, Hypnotics, Sedatives into Lymphatics, Percutaneous Approach
      • 3E0W3T Destructive Agent
        • 3E0W3TZ Introduction of Destructive Agent into Lymphatics, Percutaneous Approach